Literature DB >> 4018785

Trichosporon beigelii endocarditis as a complication of peritoneovenous shunt.

C V Reyes, M M Stanley, J W Rippon.   

Abstract

Trichosporon is a common cause of superficial mycotic infection but has rarely been associated with endocarditis. The case of a patient who had a peritoneovenous shunt for chronic intractable ascites due to Laennec liver cirrhosis is described. The shunt was revised on several occasions, and the last procedure was complicated by a draining skin sinus wound. To the authors' knowledge, this is the first reported case of Trichosporon endocarditis complicating a peritoneovenous shunt.

Entities:  

Mesh:

Year:  1985        PMID: 4018785     DOI: 10.1016/s0046-8177(85)80262-8

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  Nonbacterial thrombotic endocarditis associated with the use of a peritoneovenous shunt.

Authors:  M Kaplansky; C V Reyes
Journal:  Tex Heart Inst J       Date:  1987-06

2.  Right-sided endocarditis secondary to a peritoneovenous shunt.

Authors:  Jennifer Higgins; Hossein Shayan; Guy Fradet
Journal:  Can J Cardiol       Date:  2010 Aug-Sep       Impact factor: 5.223

Review 3.  Current knowledge of Trichosporon spp. and Trichosporonosis.

Authors:  Arnaldo L Colombo; Ana Carolina B Padovan; Guilherme M Chaves
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

4.  Long-term survival of a patient with prosthetic valve endocarditis due to Trichosporon beigelii.

Authors:  J Martinez-Lacasa; J Maña; R Niubó; G Rufi; A Saez; F Fernández-Nogués
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267

Review 5.  Prosthetic valve endocarditis by Trichosporon mucoides: A case report and review of literature.

Authors:  Tae Hoon Oh; Sung Un Shin; Soo Sung Kim; Seong Eun Kim; Uh Jin Kim; Seung-Ji Kang; Hee-Chang Jang; Sook In Jung; Jong-Hee Shin; Kyung-Hwa Park
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.